![]() |
![]() |
Legal status
Patent not validated
(51) | INT.CL. | C12N 15/113 | |
C12N 15/10 | |||
A61K 31/712 |
(11) | Number of the document | 3507366 |
(13) | Kind of document | T |
(96) | European patent application number | 17771348.4 |
Date of filing the European patent application | 2017-08-31 | |
(97) | Date of publication of the European application | 2019-07-10 |
(45) | Date of publication and mention of the grant of the patent | 2020-10-07 |
(46) | Date of publication of the claims translation |
(86) | Number | PCT/EP2017/071912 |
Date | 2017-08-31 |
(87) | Number | WO 2018/041973 |
Date | 2018-03-08 |
(30) | Number | Date | Country code |
201614858 | 2016-09-01 | GB | |
201616374 | 2016-09-27 | GB | |
201621467 | 2016-12-16 | GB | |
201703034 | 2017-02-24 | GB | |
201707508 | 2017-05-10 | GB |
(72) |
TURUNEN, Janne Juha, NL
AALTO, Antti, NL
KLEIN, Bart, NL
VAN SINT FIET, Lenka, NL
BOUDET, Julien Auguste Germain, NL
|
(73) |
ProQR Therapeutics II B.V.,
Zernikedreef 9, 2333 CK Leiden,
NL
|
(54) | CHEMICALLY MODIFIED SINGLE-STRANDED RNA-EDITING OLIGONUCLEOTIDES |
CHEMICALLY MODIFIED SINGLE-STRANDED RNA-EDITING OLIGONUCLEOTIDES |